• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Infectious Diseases Society of America (IDSA) POSITION STATEMENT: Why IDSA Did Not Endorse the Surviving Sepsis Campaign Guidelines.美国传染病学会 (IDSA) 立场声明:为何 IDSA 未认可拯救脓毒症运动指南。
Clin Infect Dis. 2018 May 2;66(10):1631-1635. doi: 10.1093/cid/cix997.
2
IDSA Did Not Endorse the Surviving Sepsis Campaign Guidelines.美国感染病学会未认可《拯救脓毒症运动指南》。
Clin Infect Dis. 2018 May 17;66(11):1815-1816. doi: 10.1093/cid/cix1114.
3
The Survival of the Surviving Sepsis Campaign.存活的脓毒症运动的存活。
Med Clin North Am. 2022 Nov;106(6):1109-1117. doi: 10.1016/j.mcna.2022.08.006.
4
Treatment of Pediatric Septic Shock With the Surviving Sepsis Campaign Guidelines and PICU Patient Outcomes.采用脓毒症存活策略指南治疗小儿脓毒性休克及儿科重症监护病房患者的预后
Pediatr Crit Care Med. 2016 Oct;17(10):e451-e458. doi: 10.1097/PCC.0000000000000906.
5
[Surviving Sepsis Campaign update 2018: the 1 h bundle : Background to the new recommendations].[2018年拯救脓毒症运动更新:1小时集束化治疗:新推荐的背景]
Anaesthesist. 2019 Apr;68(4):204-207. doi: 10.1007/s00101-019-0571-5.
6
Infectious Diseases Society of America Position Paper: Recommended Revisions to the National Severe Sepsis and Septic Shock Early Management Bundle (SEP-1) Sepsis Quality Measure.美国传染病学会立场文件:国家严重脓毒症和脓毒性休克早期管理捆绑包(SEP-1)脓毒症质量测量推荐修订版。
Clin Infect Dis. 2021 Feb 16;72(4):541-552. doi: 10.1093/cid/ciaa059.
7
Surviving Sepsis Campaign: Research Priorities for Sepsis and Septic Shock.拯救脓毒症运动:脓毒症和脓毒性休克的研究重点。
Crit Care Med. 2018 Aug;46(8):1334-1356. doi: 10.1097/CCM.0000000000003225.
8
Surviving sepsis in the critical care environment.在重症监护环境中存活的脓毒症患者
Crit Care Nurs Q. 2015 Apr-Jun;38(2):137-42. doi: 10.1097/CNQ.0000000000000054.
9
Summary of the 2016 International Surviving Sepsis Campaign: A Clinician's Guide.《2016年国际脓毒症存活指南:临床医生指南》摘要
Crit Care Nurs Clin North Am. 2018 Sep;30(3):311-321. doi: 10.1016/j.cnc.2018.04.001. Epub 2018 Jul 9.
10
CE: Managing Sepsis and Septic Shock: Current Guidelines and Definitions.CE:脓毒症及脓毒性休克的管理:当前指南与定义
Am J Nurs. 2018 Feb;118(2):34-39. doi: 10.1097/01.NAJ.0000530223.33211.f5.

引用本文的文献

1
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024.《2024年日本脓毒症和脓毒性休克管理临床实践指南》
J Intensive Care. 2025 Mar 14;13(1):15. doi: 10.1186/s40560-025-00776-0.
2
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024.《2024年日本脓毒症和脓毒性休克管理临床实践指南》
Acute Med Surg. 2025 Feb 24;12(1):e70037. doi: 10.1002/ams2.70037. eCollection 2025 Jan-Dec.
3
The Effect of Severe Sepsis and Septic Shock Management Bundle (SEP-1) Compliance and Implementation on Mortality Among Patients With Sepsis : A Systematic Review.严重脓毒症和脓毒性休克管理集束化治疗(SEP-1)的依从性及实施情况对脓毒症患者死亡率的影响:一项系统评价
Ann Intern Med. 2025 Apr;178(4):543-557. doi: 10.7326/ANNALS-24-02426. Epub 2025 Feb 18.
4
The elusive concept of appropriate antibiotic for septic patients when a pathogen is not detected by standard culture methods.当标准培养方法未检测到病原体时,针对脓毒症患者使用合适抗生素这一难以捉摸的概念。
Crit Care. 2025 Jan 6;29(1):7. doi: 10.1186/s13054-024-05240-3.
5
Optical Bionanosensors for Sepsis Diagnostics.用于脓毒症诊断的光学生物纳米传感器
Small. 2025 Feb;21(8):e2409042. doi: 10.1002/smll.202409042. Epub 2025 Jan 2.
6
Early management of adult sepsis and septic shock: Korean clinical practice guidelines.成人脓毒症和脓毒性休克的早期管理:韩国临床实践指南
Acute Crit Care. 2024 Nov;39(4):445-472. doi: 10.4266/acc.2024.00920. Epub 2024 Nov 18.
7
Prevalence and predictors of confirmed infection in patients receiving empiric antimicrobials in the intensive care unit: a retrospective cohort study.重症监护病房中接受经验性抗菌药物治疗患者确诊感染的患病率及预测因素:一项回顾性队列研究。
Braz J Anesthesiol. 2025 Jan-Feb;75(1):844567. doi: 10.1016/j.bjane.2024.844567. Epub 2024 Oct 24.
8
Validation and comparison of triage-based screening strategies for sepsis.基于分诊的脓毒症筛查策略的验证和比较。
Am J Emerg Med. 2024 Nov;85:140-147. doi: 10.1016/j.ajem.2024.08.037. Epub 2024 Sep 2.
9
Exploring the Mediating Role of Multiple Organ Dysfunction in Sepsis-Induced Disseminated Intravascular Coagulation and Its Impact on Worsening Prognosis.探讨多器官功能障碍在脓毒症相关性弥散性血管内凝血中的中介作用及其对预后恶化的影响。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241271358. doi: 10.1177/10760296241271358.
10
Effectiveness and Safety of an Emergency Department Code Sepsis Protocol: A Pragmatic Clinical Trial.急诊科脓毒症方案的有效性和安全性:一项实用临床试验。
Ann Am Thorac Soc. 2024 Nov;21(11):1560-1571. doi: 10.1513/AnnalsATS.202403-286OC.

本文引用的文献

1
Monotherapy Is Adequate for Septic Shock Due to Gram-Negative Organisms.对于革兰氏阴性菌引起的感染性休克,单一疗法就足够了。
Crit Care Med. 2017 Nov;45(11):1930-1932. doi: 10.1097/CCM.0000000000002678.
2
Antibiotic Combination Therapy for Patients With Gram-Negative Septic Shock.革兰氏阴性菌败血症休克患者的抗生素联合治疗
Crit Care Med. 2017 Nov;45(11):1933-1936. doi: 10.1097/CCM.0000000000002677.
3
The Impact of the Sepsis-3 Septic Shock Definition on Previously Defined Septic Shock Patients.脓毒症-3脓毒性休克定义对先前定义的脓毒性休克患者的影响。
Crit Care Med. 2017 Sep;45(9):1436-1442. doi: 10.1097/CCM.0000000000002512.
4
Time to Treatment and Mortality during Mandated Emergency Care for Sepsis.脓毒症强制紧急治疗的治疗时间与死亡率
N Engl J Med. 2017 Jun 8;376(23):2235-2244. doi: 10.1056/NEJMoa1703058. Epub 2017 May 21.
5
Antibiotics for Sepsis: Does Each Hour Really Count, or Is It Incestuous Amplification?用于治疗脓毒症的抗生素:每一小时真的都至关重要吗?还是存在恶性循环式的放大效应?
Am J Respir Crit Care Med. 2017 Oct 1;196(7):800-802. doi: 10.1164/rccm.201703-0621ED.
6
The Timing of Early Antibiotics and Hospital Mortality in Sepsis.脓毒症中早期使用抗生素的时机与医院死亡率
Am J Respir Crit Care Med. 2017 Oct 1;196(7):856-863. doi: 10.1164/rccm.201609-1848OC.
7
A Users' Guide to the 2016 Surviving Sepsis Guidelines.《2016年拯救脓毒症指南用户指南》
Crit Care Med. 2017 Mar;45(3):381-385. doi: 10.1097/CCM.0000000000002257.
8
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.拯救脓毒症运动:脓毒症与脓毒性休克管理国际指南:2016版
Crit Care Med. 2017 Mar;45(3):486-552. doi: 10.1097/CCM.0000000000002255.
9
Early Goal-Directed Therapy for Sepsis: A Novel Solution for Discordant Survival Outcomes in Clinical Trials.脓毒症的早期目标导向治疗:临床试验中生存结果不一致问题的新解决方案。
Crit Care Med. 2017 Apr;45(4):607-614. doi: 10.1097/CCM.0000000000002235.
10
Duration of Antibiotic Treatment in Community-Acquired Pneumonia: A Multicenter Randomized Clinical Trial.社区获得性肺炎的抗生素治疗时间:一项多中心随机临床试验。
JAMA Intern Med. 2016 Sep 1;176(9):1257-65. doi: 10.1001/jamainternmed.2016.3633.

美国传染病学会 (IDSA) 立场声明:为何 IDSA 未认可拯救脓毒症运动指南。

Infectious Diseases Society of America (IDSA) POSITION STATEMENT: Why IDSA Did Not Endorse the Surviving Sepsis Campaign Guidelines.

出版信息

Clin Infect Dis. 2018 May 2;66(10):1631-1635. doi: 10.1093/cid/cix997.

DOI:10.1093/cid/cix997
PMID:29182749
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6927848/
Abstract

IDSA did not endorse the 2016 Surviving Sepsis Campaign Guidelines despite being represented in the working group that drafted the guidelines document. Leadership from the IDSA, the Surviving Sepsis Campaign Guidelines, and the Society of Critical Care Medicine had numerous amicable discussions primarily regarding the bolded, rated guidelines recommendations. Our societies had different perspectives, however, regarding the interpretation of the major studies that informed the guidelines' recommendations, thus leading us to different conclusions and different perspectives on the recommendations. IDSA consequently elected not to endorse the guidelines. IDSA nonetheless hopes to be able to continue collaborating with the Surviving Sepsis Campaign and the Society of Critical Care Medicine to resolve our differences and to develop further strategies together to prevent sepsis and septic shock as well as reduce death and disability from these conditions both nationally and globally.

摘要

尽管参与了制定指南文件的工作组,但 IDSA 并未认可 2016 年的《拯救脓毒症运动指南》。来自 IDSA、拯救脓毒症运动指南和重症监护医学会的领导层进行了多次友好的讨论,主要涉及加粗的、有评级的指南推荐。然而,我们的学会对于指导方针建议所依据的主要研究有不同的看法,因此导致我们对建议有不同的结论和看法。因此,IDSA 选择不认可这些指南。尽管如此,IDSA 仍希望能够继续与拯救脓毒症运动和重症监护医学会合作,解决我们之间的分歧,并共同制定进一步的策略,以预防脓毒症和脓毒性休克,并减少这些疾病在国内外造成的死亡和残疾。